Asthma Trial, Recruiting NCT05572177 Sponsor: University of South Florida Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT05572177
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 12 years old but under 18 years old at the time of enrolment
  • People who have been diagnosed with mild, moderate, or severe persistent asthma, confirmed by a clinic doctor
  • People who speak English
  • People who are not planning to move out of the Tampa Bay area during the trial period
  • People who have access to a suitable iPhone or Android smartphone that can be used with the trial app

Who may not be able to join:

  • People who have a mental health condition or developmental disorder that may make it difficult to manage a long-term health condition on their own
  • People who have another chronic lung disease, or conditions such as cystic fibrosis, neuromuscular disease, immune system disorders, or autoimmune disorders, or who have blindness or severe vision impairment that may affect their ability to use the mobile app
  • People who took part in the app development phase of the research project this trial is connected to

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy Alman, PhD, University of South Florida

Phone: 813-974-5193

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of South Florida
Registry
ClinicalTrials.gov
Start date
26 June 2023
Est. completion
30 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment rate (number recruited per month); Retention rate (proportion that complete the 6-month trial); Technical feasibility (percentage of screened population); Mean overall usability score obtained from the Health-ITUES; Average app usage per day; Adherence to app reminders (proportion of app reminders)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov